The epidemiological landscape of multiple myeloma: a global cancer registry estimate of disease burden, risk factors, and temporal trends.
暂无分享,去创建一个
Zhi‐Jie Zheng | Wanghong Xu | M. Withers | D. Lucero-Prisno | Junjie Huang | Veeleah Lok | Lin Zhang | Edmar Elcarte | Sze Chai Chan | Martin C. S. Wong | D. Lucero‐Prisno | S. Chan
[1] R. Kolhe,et al. Epidemiology, Staging, and Management of Multiple Myeloma , 2021, Medical sciences.
[2] L. Lipscombe,et al. Association between diabetes and haematological malignancies: a population-based study , 2021, Diabetologia.
[3] D. Heimburger,et al. Cancer Control in Low- and Middle-Income Countries: Is It Time to Consider Screening? , 2019, Journal of global oncology.
[4] G. Colditz,et al. Body mass index throughout adulthood, physical activity, and risk of multiple myeloma: a prospective analysis in three large cohorts , 2018, British Journal of Cancer.
[5] Gretchen A. Stevens,et al. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults , 2017, Lancet.
[6] E. Igbigbi,et al. Multiple myeloma in Niger Delta, Nigeria: complications and the outcome of palliative interventions , 2017, Cancer management and research.
[7] D. Kazandjian. Multiple myeloma epidemiology and survival: A unique malignancy. , 2016, Seminars in oncology.
[8] O. Landgren,et al. A look backward and forward in the regulatory and treatment history of multiple myeloma: Approval of novel-novel agents, new drug development, and longer patient survival. , 2016, Seminars in oncology.
[9] C. la Vecchia,et al. Alcohol drinking and multiple myeloma risk – a systematic review and meta-analysis of the dose–risk relationship , 2014, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[10] M. Dimopoulos,et al. Tobacco smoking and risk of multiple myeloma: A meta‐analysis of 40 observational studies , 2013, International journal of cancer.
[11] J. Ferlay,et al. Fifty years of cancer incidence: CI5 I–IX , 2010, International journal of cancer.
[12] R. Tiwari,et al. (www.interscience.wiley.com) DOI: 10.1002/sim.3733 Estimating average annual per cent change in trend analysis , 2022 .
[13] L. Pantanowitz,et al. Higher prevalence of monoclonal gammopathy of undetermined significance in African Americans than whites--the unknown role of underlying HIV infection. , 2006, Journal of the National Medical Association.
[14] R. Hoover,et al. Risk of monoclonal gammopathy of undetermined significance (MGUS) and subsequent multiple myeloma among African American and white veterans in the United States. , 2005, Blood.
[15] Alan D. Lopez,et al. Counting the dead and what they died from: an assessment of the global status of cause of death data. , 2005, Bulletin of the World Health Organization.
[16] O. Nwabuko,et al. Risk factors versus causal inferences: the implications on multiple myeloma in developed versus developing countries , 2019 .
[17] J. Ferlay,et al. Epidemiological patterns of leukaemia in 184 countries: a population-based study. , 2018, The Lancet. Haematology.
[18] R. Clapp,et al. Environmental and Occupational Causes of Cancer: New Evidence 2005-2007 , 2008, Reviews on environmental health.
[19] K. Matsuo,et al. Risk factors for multiple myeloma: evidence from the Japan Collaborative Cohort (JACC) study. , 2006, Asian Pacific journal of cancer prevention : APJCP.